Breast cancer (BC) classified into specific molecular subtypes according to the presence or absence of hormone receptors (ER, PR) and the HER2 protein (Effi et al., 2016; Singh et al., 2022; Singh et al., 2025). This evidence concerns the gene ERBB2 and breast carcinoma.